Plasma sars-cov-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized covid-19

HIGHLIGHTS

  • who: Katherine D. Wick from the Cardiovascular Research Institute, University of California San Francisco, Parnassus Ave, HSE, San Francisco, CA, USA have published the research: Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19, in the Journal: (JOURNAL)
  • what: The aims of this study were to investigate the relationship between SARS-CoV-2 nucleocapsid antigen (N-antigen) levels detected in plasma at study enrollment (D0) and_(1) biomarkers of tissue damage and host response, to COVID-19 and_(2) both short-term clinical deterioration and longer . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?